Literature DB >> 29485940

Surveillance of Intrauterine Opioid Exposures Using Electronic Health Records.

Eric S Hall1,2,3, Scott L Wexelblatt1,2, James M Greenberg1,2.   

Abstract

The objective was to use population-based electronic health records for surveillance of intrauterine exposures to substances of abuse, including opioids, and to monitor changes in exposure rates over time. This retrospective, descriptive analysis utilized geocoded neonatal physician billing records representing intrauterine exposures to substances of abuse detected through universal maternal drug testing. Census tract-level exposure rates were identified among the newborn population of Hamilton County, Ohio between 2014 and 2016. Among 27,896 newborns, the authors detected an intrauterine opioid exposure rate of 37.9 per 1000 infants, with 10.5 per 1000 experiencing severe opioid withdrawal (neonatal abstinence syndrome). Individual data were mapped to 222 US census tracts. Tract-level opioid exposure rates ranged from 0.0 to 607.1 (median: 32.9) per 1000 live births. Secondary use of electronic health record data has potential to aid in intrauterine opioid exposure and other public health surveillance efforts without disrupting clinical workflows or placing an additional burden on limited resources. Surveillance of intrauterine opioid exposures may inform stakeholders and enable targeting of interventions and prevention strategies toward the highest risk populations.

Entities:  

Keywords:  electronic health records; neonatal abstinence syndrome; newborn; opioid; public health surveillance

Mesh:

Substances:

Year:  2018        PMID: 29485940      PMCID: PMC6276597          DOI: 10.1089/pop.2017.0184

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  18 in total

Review 1.  Neonatal Abstinence Syndrome.

Authors:  Karen McQueen; Jodie Murphy-Oikonen
Journal:  N Engl J Med       Date:  2016-12-22       Impact factor: 91.245

2.  Cohort Analysis of a Pharmacokinetic-Modeled Methadone Weaning Optimization for Neonatal Abstinence Syndrome.

Authors:  Eric S Hall; Jareen Meinzen-Derr; Scott L Wexelblatt
Journal:  J Pediatr       Date:  2015-10-21       Impact factor: 4.406

3.  A Public Health Response to Opioid Use in Pregnancy.

Authors:  Stephen W Patrick; Davida M Schiff
Journal:  Pediatrics       Date:  2017-02-20       Impact factor: 7.124

4.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

5.  Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.

Authors:  Joshua D Brown; Amie J Goodin; Jeffery C Talbert
Journal:  J Rural Health       Date:  2017-07-07       Impact factor: 4.333

6.  Rates of Neonatal Abstinence Syndrome Amid Efforts to Combat the Opioid Abuse Epidemic.

Authors:  Joshua D Brown; Pratik A Doshi; Nathan J Pauly; Jeffery C Talbert
Journal:  JAMA Pediatr       Date:  2016-11-01       Impact factor: 16.193

Review 7.  Neonatal abstinence syndrome.

Authors:  Prabhakar Kocherlakota
Journal:  Pediatrics       Date:  2014-08       Impact factor: 7.124

8.  Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013.

Authors:  Jean Y Ko; Stephen W Patrick; Van T Tong; Roshni Patel; Jennifer N Lind; Wanda D Barfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-12       Impact factor: 17.586

9.  Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.

Authors:  S W Patrick; M M Davis; C U Lehmann; C U Lehman; W O Cooper
Journal:  J Perinatol       Date:  2015-04-30       Impact factor: 2.521

10.  Implementation of a statewide surveillance system for neonatal abstinence syndrome - Tennessee, 2013.

Authors:  Michael D Warren; Angela M Miller; Julie Traylor; Audrey Bauer; Stephen W Patrick
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-02-13       Impact factor: 17.586

View more
  2 in total

1.  Rates of substance and polysubstance use through universal maternal testing at the time of delivery.

Authors:  Brittany L Smith; Eric S Hall; Jennifer M McAllister; Michael P Marcotte; Kenneth D R Setchell; Vandana Megaraj; Kristine L Jimenez; T John Winhusen; Scott L Wexelblatt
Journal:  J Perinatol       Date:  2022-02-17       Impact factor: 3.225

2.  Well-Child Care Adherence After Intrauterine Opioid Exposure.

Authors:  Neera K Goyal; Jessica F Rohde; Vanessa Short; Stephen W Patrick; Diane Abatemarco; Esther K Chung
Journal:  Pediatrics       Date:  2020-01-02       Impact factor: 7.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.